NASDAQ · CYRX
Industrials · Integrated Freight & Logistics
$16.45
Up+$0.26 (+1.58%)
Updated Nov 4, 2026, 8:58 PM
SID Score
6.6/10
Composite research score
Smart Money
—
Institutional and insider signal
Price performance · CYRX
1M range · 21 trading sessions · Daily adjusted prices
Prices through Nov 3, 2026
CYRX closed at $16.45 after 21 trading sessions, down 7.58% for the selected period.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 3, 2026 | $16.28 | $16.96 | $16.28 | $16.45 | 2.51M |
| Nov 2, 2026 | $17.45 | $17.505 | $16.09 | $16.23 | 1.23M |
| Oct 30, 2026 | $17.94 | $18.25 | $17.14 | $17.29 | 1.04M |
| Oct 29, 2026 | $18.66 | $18.69 | $18.235 | $18.29 | 2.23M |
| Oct 28, 2026 | $18.33 | $18.88 | $18.13 | $18.64 | 657.33K |
| Oct 27, 2026 | $17.82 | $18.44 | $17.60 | $18.41 | 640.17K |
| Oct 26, 2026 | $17.97 | $18.19 | $17.67 | $17.79 | 438.34K |
| Oct 23, 2026 | $17.74 | $18.00 | $17.2764 | $17.98 | 529.51K |
| Oct 22, 2026 | $18.42 | $18.73 | $17.5501 | $17.83 | 792.36K |
| Oct 21, 2026 | $17.42 | $18.67 | $17.42 | $18.53 | 812.57K |
| Oct 20, 2026 | $16.91 | $17.51 | $16.91 | $17.44 | 1.09M |
| Oct 19, 2026 | $16.93 | $17.27 | $16.855 | $16.98 | 517.37K |
| Oct 16, 2026 | $17.01 | $17.14 | $16.655 | $16.84 | 706.43K |
| Oct 15, 2026 | $16.49 | $17.13 | $16.131 | $17.07 | 455.03K |
| Oct 14, 2026 | $16.75 | $17.16 | $16.57 | $16.64 | 558.18K |
| Oct 13, 2026 | $17.11 | $17.14 | $16.79 | $16.95 | 575.58K |
| Oct 12, 2026 | $17.22 | $17.28 | $16.56 | $16.84 | 602.23K |
| Oct 9, 2026 | $16.90 | $17.655 | $16.90 | $17.35 | 479.87K |
| Oct 8, 2026 | $17.20 | $17.42 | $16.645 | $16.90 | 1.21M |
| Oct 7, 2026 | $17.36 | $17.55 | $17.126 | $17.35 | 1.37M |
| Oct 6, 2026 | $18.36 | $18.36 | $17.445 | $17.80 | 1.17M |
The latest Smart Investors Daily articles mentioning CYRX.
Company
Market Activity
Research & News
CYRX research
Company profile and research snapshot.
CryoPort Inc is a leader serving the life sciences industry as a provider of integrated temperature-controlled supply chain solutions supporting the life sciences in the biopharma/pharma, animal health, and reproductive medicine markets. It operates in two reportable segments: Life Sciences Services and Life Sciences Products. Geographically the company operates in the Americas, Europe, the Middle East and Africa (EMEA), and Asia Pacific (APAC), generating a majority of its revenue from the Americas.
Visit company websiteConsensus and target data currently published for this company.
| Date | Firm | Rating | Target |
|---|---|---|---|
| Oct 13, 2026 | BTIG | Buy | — |
| Oct 1, 2026 | Guggenheim | Buy | — |
| Sep 18, 2026 | BTIG | Buy | — |
| Aug 7, 2026 | Guggenheim | Buy | — |
| Aug 7, 2026 | Needham | Buy | — |
No generated briefing is available yet.
Yahoo · Oct 22, 2026
Cryoport, Inc. (Nasdaq: CYRX) ("Cryoport" or the "Company"), a leading global provider of integrated temperature-controlled supply chain solutions for the life sciences, today announced that the Company will report financial results for the third quarter ended September 30, 2026 on Thursday, November 5, 2026 after U.S. markets close.
Benzinga · Oct 13, 2026
CryoPort (NASDAQ:CYRX) held its second-quarter earnings conference call on Thursday. Below is the complete transcript from the call. This transcript is brought to you by Benzinga APIs. For real-time access to our entire
Benzinga · Oct 13, 2026
BTIG analyst David Larsen maintains CryoPort (NASDAQ:CYRX) with a Buy and raises the price target from $25 to $26.
Benzinga · Oct 1, 2026
Guggenheim analyst Subbu Nambi maintains CryoPort (NASDAQ:CYRX) with a Buy and raises the price target from $16 to $19.
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
The latest Smart Investors Daily articles mentioning CYRX.
